All entries for: AniMusCure Inc.

March 2, 2026

AniMusCure Inc.

Orphan Drug Designation

treatment of amyotrophic lateral sclerosis

Disease Area: Rare Disease
September 8, 2025

AniMusCure Inc.

Orphan Drug Designation

FDA orphan drug designation: treatment of Duchenne muscular dystrophy (DMD)

Disease Area: Rare Diseases
Scroll to Top